Bright Minds Biosciences to present at two healthcare conferences in September 2026

Sep 4, 2026 20:30 (49d ago)

Verifying

Bright Minds Biosciences will present at two healthcare and investment conferences in September 2026.
September 9 and September 15 are the scheduled presentation dates.
The company develops selective 5-HT2 agonists for neurological and psychiatric disorders.

The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.